Taken together, these findings suggest that p57KIP2 modulates stress-activated signaling by functioning as an endogenous inhibitor of JNK/SAPK..     ///    The carboxyl-terminal QT domain of p57KIP2 is crucial for the inhibition of JNK/SAPK. 